Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Allon Therapeutics Inc NPCUF

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).


GREY:NPCUF - Post by User

Post by Aberta1on Jan 19, 2017 6:44pm
173 Views
Post# 25731283

NAPEC adopts new rules for nominating directors

NAPEC adopts new rules for nominating directors

NAPEC adopts new rules for nominating directors

 

2017-01-19 17:34 ET - News Release

 

Mr. Pierre Gauthier reports

NAPEC INC. ANNOUNCES ADOPTION OF AN ADVANCE NOTICE BY-LAW

NAPEC Inc. has adopted an advance notice bylaw. The bylaw requires that an advance notice be given to NAPEC when shareholders intend to nominate candidates for election as directors of the corporation otherwise than pursuant to (i) a notice of meeting given in accordance with the provisions of the Canada Business Corporations Act, or (ii) a shareholder proposal made in accordance with the provisions of the act.

In the case of an annual meeting of shareholders, the advance notice to NAPEC must be given at least 30 days and no more than 65 days before the date of the annual meeting, provided, however, that if the annual meeting of shareholders is to be held less than 50 days after the date of the first public announcement of the date of the annual meeting, a shareholder nominating a candidate may give notice no later than the close of business on the 10th day following the date of such public announcement. In the case of a special meeting (which is not also an annual meeting) of shareholders called for the purpose of electing directors (whether or not called for other purposes), the advance notice to NAPEC must be given no later than the close of business on the 15th day following the date of the first public announcement of the date of the special meeting of shareholders.

The bylaw takes effect immediately until ratified by shareholders at the next annual and special meeting of shareholders. The full text of the bylaw is available under the corporation's profile in the SEDAR database at SEDAR.

Overview of the corporation

NAPEC is a company operating in the energy sector. The corporation is a leading provider of construction and maintenance services to the public utility and heavy industrial markets, mainly in Quebec, Ontario, and Eastern United States.

<< Previous
Bullboard Posts
Next >>